Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis

ENeurologicalSci
Tino PrellJulian Grosskreutz

Abstract

The study aimed to determine the impact of emotional well-being on disease aggressiveness and survival in amyotrophic lateral sclerosis (ALS). In 224 patients with ALS (without significant cognitive deficits) the revised ALS Functional Rating Scale (physical function), the ALS Assessment Questionnaire (ALSAQ-40) for health-related Quality of Life and survival data were collected. Data analysis comprised logistic regression, Kaplan-Meier curves analyses and Cox regression model. Most patients reported to be worried about how the disease will affect them in the future and 67% reported to feel depressed. Patients with good emotional well-being were characterized by better physical function (higher ALSFRS-R) and lower disease aggressiveness. The association between high emotional well-being and lower disease aggressiveness was confirmed in the univariate analysis and also after adjustment for known predictors of disease progression. In the Kaplan-Meier survival curve analysis the overall 1-year, 2-year and 3-year mortality did not significantly differ between patients with poor and good emotional well-being. Our study demonstrates an association between emotional well-being and disease progression. Knowing that subjective well-bein...Continue Reading

References

Oct 17, 1996·The New England Journal of Medicine·D MichelsonP Gold
Jan 20, 1998·The American Journal of Psychiatry·A H Glassman, P A Shapiro
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·B R BrooksUNKNOWN World Federation of Neurology Research Group on Motor Neuron Diseases
Aug 4, 2001·Psychosomatic Medicine·M de GrootP J Lustman
Jul 13, 2011·Journal of Aging Research·Jinmyoung ChoLeonard W Poon
Sep 16, 2011·Journal of Behavioral Medicine·Sanne M A LamersErnst T Bohlmeijer
Jun 21, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Sharon AbrahamsThomas H Bak
Sep 17, 2014·Annals of Neurology·Neil G SimonMatthew C Kiernan
Dec 17, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Zachary Simmons
Jul 15, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Julie LabraSteve Vucic
Jul 9, 2016·JAMA Ophthalmology·Gwyneth ReesEcosse L Lamoureux
Oct 25, 2016·Journal of the Neurological Sciences·Petter SandstedtMarie Kierkegaard
Jul 15, 2017·Applied Psychology. Health and Well-being·Ed DienerDesiree Delgadillo-Chase
Oct 11, 2017·Journal of the Neurological Sciences·Yasuyuki OhtaKoji Abe
Feb 13, 2018·Neurology. Clinical Practice·Meredith BockCatherine Lomen-Hoerth
Jan 1, 2019·Journal of the Neurological Sciences·Tino PrellJulian Grosskreutz
Jan 15, 2019·Collabra. Psychology·Ed DienerShigehiro Oishi
Feb 12, 2019·Frontiers in Aging Neuroscience·Tino PrellJulian Grosskreutz

❮ Previous
Next ❯

Citations

Jan 15, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Corrado CabonaClaudia Caponnetto

❮ Previous
Next ❯

Software Mentioned

SPSS
ERANET E - RARE

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.